Device Trial Radar · NCT02376868
Maestro Agreement and Precision Study II
Last checked: Nov 19, 2026Latest source record: Jun 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
May 2015
Primary completion
Sep 2015
Study completion Sep 2015
Sponsor
- Lead sponsor
- Topcon Medical Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 3, 2015
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, Full Retinal Thickness, and Ganglion Cell Thickness between the Maestro and iVue OCT devices.
Conditions
- Normal Healthy Subjects With No Known Ocular Diseases
- Glaucomatous Eyes
- Eyes With Retinal Diseases
Interventions
3D OCT-1 MaestroDevice
OCT machines used for diagnostic purposes
iVueDevice
OCT machines used for diagnostic purposes
Primary outcomes
What the sponsor says the trial is designed to measure.
- Optic Disc Measurements (Optic Disc/Cup Size)Time frame: 1 Hour
- Retinal Nerve Fiber Layer (RNFL) Thickness Measurements At Different Clock HoursTime frame: 1 Hour
- Full Retinal Thickness MeasurementsTime frame: 1 Hour
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Western University of Health Sciences
Pomona, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.